In addition, blocking RPT3 Thr-25 phosphorylation or knocking down DYRK2 resulted in slower proliferation of human cells, while overexpression of DYRK2, as seen in several cancer types (Santarius et al., 2010), showed opposite results (Guo et al., 2016). The gene discussed is DYRK2; the disease is cancer.